Urokinase-type plasminogen activator (uPA) and its receptor (uPAR): development of antagonists of uPA/uPAR interaction and their effects in vitro and in vivo.
about
The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodelingDrug development against metastasis-related genes and their pathways: A rationale for cancer therapySynthesis and characterization of an (111)In-labeled peptide for the in vivo localization of human cancers expressing the urokinase-type plasminogen activator receptor (uPAR)Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients: a prospective observational study.Pathobiology of brain metastases.Analysis of soluble urokinase plasminogen activator receptor in multiple myeloma for predicting prognosis.Design, synthesis, biochemical studies, cellular characterization, and structure-based computational studies of small molecules targeting the urokinase receptor.Bispecific targeting of EGFR and uPAR in a mouse model of head and neck squamous cell carcinoma.Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors.Tumor-associated proteolytic factors uPA and PAI-1: critical appraisal of their clinical relevance in breast cancer and their integration into decision-support algorithms.Reactive oxygen species and tumor metastasisRadiometallated peptides targeting guanylate cyclase C and the urokinase-type plasminogen activator receptor.A molecular imaging primer: modalities, imaging agents, and applications.Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines.T-SP1: a novel serine protease-like protein predominantly expressed in testis.MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.Lipids isolated from bone induce the migration of human breast cancer cells.Regulation of urokinase receptor proteolytic function by the tetraspanin CD82.Relationship between urokinase-type plasminogen activator receptor and vascular endothelial growth factor expression and metastasis of gallbladder cancer.Challenges for drug discovery - a case study of urokinase receptor inhibition
P2860
Q28257803-914E3E67-E499-474C-AECA-9AB51CEB2EF2Q29010479-C086F9AA-5170-4FA3-8921-97263B594686Q33912826-6B2A1AB7-C9BF-411E-BE20-2042810231BDQ35567173-6271463E-5034-4643-89ED-D4B0F971BF18Q36056424-965DD70A-9698-40CB-846F-DD6A8C1264BAQ36085907-5F51D57C-1133-4DDC-B3AD-3F75FEC38A1EQ36221040-4DB8345C-0FF6-46DD-965D-8451181ACCF3Q36346628-9A3F5177-DDA3-4010-8999-DA505E4DA928Q36490382-89ED72B3-4F77-436B-BE0E-EEC04BAAC46FQ36761523-52C27053-2A9A-487B-8374-DD97B21286D5Q37462315-936AAC24-8B5F-4250-B5A6-BB695A7C9C32Q37783622-D3FA9A66-AFB1-4D76-AD10-7DD2D1DCF4D0Q38005672-657D6D3C-44E7-43E1-B449-C05DB9F29BE4Q38942148-CF8D9C2E-B322-47BD-A0C2-F541348D981DQ39930941-7BE89208-1F92-4895-9A87-A59F42CD05EDQ40147018-8D30E9E5-2FC4-4A6E-916A-147E2A85A288Q40324408-3C2765D8-C2EF-4281-BFEE-762F174ABF9EQ40464543-158B3C1D-5B69-45A7-A2ED-4EF259F8E611Q41878292-DCDFFE67-2C65-44D0-866B-FEE4E0A12F3EQ41908264-99B39A20-21EC-4A86-8886-D2032F398CAE
P2860
Urokinase-type plasminogen activator (uPA) and its receptor (uPAR): development of antagonists of uPA/uPAR interaction and their effects in vitro and in vivo.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Urokinase-type plasminogen act ...... effects in vitro and in vivo.
@ast
Urokinase-type plasminogen act ...... effects in vitro and in vivo.
@en
type
label
Urokinase-type plasminogen act ...... effects in vitro and in vivo.
@ast
Urokinase-type plasminogen act ...... effects in vitro and in vivo.
@en
prefLabel
Urokinase-type plasminogen act ...... effects in vitro and in vivo.
@ast
Urokinase-type plasminogen act ...... effects in vitro and in vivo.
@en
P2093
P356
P1476
Urokinase-type plasminogen act ...... effects in vitro and in vivo.
@en
P2093
Achim Krüger
Charlotte Kopitz
Horst Kessler
Manfred Schmitt
Stefan Sperl
Ute Reuning
Viktor Magdolen
P304
P356
10.2174/1381612033454612
P577
2003-01-01T00:00:00Z